Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-01

Clinical Trial Update: Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating methylphenidate in adults with attention-deficit/hyperactivity disorder is currently recruiting in Porto Alegre, Brazil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate (Methylphenidate)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 4 | Status: RECRUITING